Natriuretic peptide receptor A as a novel target for cancer

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Zhang, Jia ^a   Zhao, Zhilong ^a   Wang, Jiansheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cancer; NPR A; Target

Indexed keywords

HORMONE PRECURSOR; NANOPARTICLE; NATRIURETIC PEPTIDE RECEPTOR A; RNA; ATRIAL NATRIURETIC FACTOR RECEPTOR; SMALL INTERFERING RNA;

BREAST ADENOCARCINOMA; CARCINOGENESIS; COLON ADENOCARCINOMA; DOWN REGULATION; GLIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; LUNG CANCER; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PLASMID; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SKIN CANCER; STOMACH CANCER; THYROID MEDULLARY CARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NEOPLASMS; PATHOLOGY;

ANIMALS; HUMANS; MICE; MOLECULAR TARGETED THERAPY; NEOPLASMS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RNA, SMALL INTERFERING;

EID: 84901981985     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-174     Document Type: Review

References (61)

1. Fiscus RR. Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals 2002, 11:175-190. 10.1159/000065431, 12393944.
2. Pedram A, Razandi M, Kehrl J, Levin ER. Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins. J Biol Chem 2000, 275:7365-7372. 10.1074/jbc.275.10.7365, 10702309.
3. Silberbach M, Roberts CT. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 2001, 13:221-231. 10.1016/S0898-6568(01)00139-5, 11306239.
4. Goy MF, Oliver PM, Purdy KE, Knowles JW, Fox JE, Mohler PJ, Qian X, Smithies O, Maeda N. Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide. Biochem J 2001, 358:379-387. 10.1042/0264-6021:3580379, 1222070, 11513736.
5. Lowe DG, Chang MS, Hellmiss R, Chen E, Singh S, Garbers DL, Goeddel DV. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J 1989, 8:1377-1384. 400964, 2569967.
6. Nagase M, Katafuchi T, Hirose S, Fujita T. Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats. J Hypertens 1997, 15:1235-1243. 10.1097/00004872-199715110-00007, 9383172.
7. Wilcox JN, Augustine A, Goeddel DV, Lowe DG. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol 1991, 11:3454-3462. 361076, 1646390.
8. Kong X, Wang X, Xu W, Behera S, Hellermann G, Kumar A, Lockey RF, Mohapatra S, Mohapatra SS. Natriuretic peptide receptor A as a novel anticancer target. Cancer Res 2008, 68:249-256. 10.1158/0008-5472.CAN-07-3086, 18172317.
9. Wang X, Raulji P, Mohapatra SS, Patel R, Hellermann G, Kong X, Vera PL, Meyer-Siegler KL, Coppola D, Mohapatra S. Natriuretic peptide receptor A as a novel target for prostate cancer. Mol Cancer 2011, 10:56. 10.1186/1476-4598-10-56, 3121714, 21586128.
10. Takahashi Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse K. Organization of the human natriuretic peptide receptor A gene. Biochem Biophys Res Commun 1998, 246:736-739. 10.1006/bbrc.1998.8693, 9618281.
11. Garg R, Pandey KN. Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression. Peptides 2005, 26:1009-1023. 10.1016/j.peptides.2004.09.022, 15911069.
12. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989, 338:78-83. 10.1038/338078a0, 2563900.
13. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 1989, 58:1155-1162. 10.1016/0092-8674(89)90513-8, 2570641.
14. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, Goeddel DV. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 1989, 341:68-72. 10.1038/341068a0, 2570358.
15. Pandey KN, Singh S. Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 1990, 265:12342-12348.
16. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 1992, 71:1-4. 10.1016/0092-8674(92)90259-F, 1356629.
17. Pandey KN. Internalization and trafficking of guanylyl cyclase/natriuretic peptide receptor-A. Peptides 2005, 26:985-1000. 10.1016/j.peptides.2004.12.020, 15911067.
18. Ogawa H, Qiu Y, Ogata CM, Misono KS. Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction. J Biol Chem 2004, 279:28625-28631. 10.1074/jbc.M313222200, 15117952.
19. Ogawa H, Qiu Y, Philo JS, Arakawa T, Ogata CM, Misono KS. Reversibly bound chloride in the atrial natriuretic peptide receptor hormone-binding domain: possible allosteric regulation and a conserved structural motif for the chloride-binding site. Protein Sci 2010, 19:544-557. 2866279, 20066666.
20. Abe T, Misono KS. Proteolytic cleavage of atrial natriuretic factor receptor in bovine adrenal membranes by endogenous metalloendopeptidase. Effects on guanylate cyclase activity and ligand-binding specificity. Eur J Biochem 1992, 209:717-724. 10.1111/j.1432-1033.1992.tb17340.x, 1358609.
21. Huo X, Abe T, Misono KS. Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide receptor: juxtamembrane hinge structure essential for transmembrane signal transduction. Biochemistry 1999, 38:16941-16951. 10.1021/bi9919448, 10606529.
22. Miyagi M, Misono KS. Disulfide bond structure of the atrial natriuretic peptide receptor extracellular domain: conserved disulfide bonds among guanylate cyclase-coupled receptors. Biochim Biophys Acta 2000, 1478:30-38. 10.1016/S0167-4838(00)00002-9, 10719172.
23. Miyagi M, Zhang X, Misono KS. Glycosylation sites in the atrial natriuretic peptide receptor: oligosaccharide structures are not required for hormone binding. Eur J Biochem 2000, 267:5758-5768. 10.1046/j.1432-1327.2000.01647.x, 10971587.
24. Koller KJ, Lipari MT, Goeddel DV. Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity. J Biol Chem 1993, 268:5997-6003.
25. Abe T, Nishiyama K, Snajdar R, He X, Misono KS. Aortic smooth muscle contains guanylate-cyclase-coupled 130-kDa atrial natriuretic factor receptor as predominant receptor form. Spontaneous switching to 60-kDa C-receptor upon cell culturing. Eur J Biochem 1993, 217:295-304. 10.1111/j.1432-1033.1993.tb18246.x, 7901005.
26. Chinkers M, Garbers DL. The protein kinase domain of the ANP receptor is required for signaling. Science 1989, 245:1392-1394. 10.1126/science.2571188, 2571188.
27. Duda T, Goraczniak RM, Sharma RK. Core sequence of ATP regulatory module in receptor guanylate cyclases. FEBS Lett 1993, 315:143-148. 10.1016/0014-5793(93)81151-O, 8093355.
28. Goraczniak RM, Duda T, Sharma RK. A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling. Biochem J 1992, 282:533-537. 1130813, 1347681.
29. Koller KJ, de Sauvage FJ, Lowe DG, Goeddel DV. Conservation of the kinase-like regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biol 1992, 12:2581-2590. 364451, 1350322.
30. Chinkers M, Singh S, Garbers DL. Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J Biol Chem 1991, 266:4088-4093.
31. Kurose H, Inagami T, Ui M. Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett 1987, 219:375-379. 10.1016/0014-5793(87)80256-9, 2886366.
32. Larose L, McNicoll N, Ong H, De Lean A. Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 1991, 30:8990-8995. 10.1021/bi00101a012, 1654083.
33. Wong SK, Ma CP, Foster DC, Chen AY, Garbers DL. The guanylyl cyclase-A receptor transduces an atrial natriuretic peptide/ATP activation signal in the absence of other proteins. J Biol Chem 1995, 270:30818-30822. 10.1074/jbc.270.51.30818, 8530525.
34. Sharma RK. Evolution of the membrane guanylate cyclase transduction system. Mol Cell Biochem 2002, 230:3-30. 10.1023/A:1014280410459, 11952094.
35. Jewett JR, Koller KJ, Goeddel DV, Lowe DG. Hormonal induction of low affinity receptor guanylyl cyclase. EMBO J 1993, 12:769-777. 413264, 8095019.
36. Larose L, Rondeau JJ, Ong H, De Lean A. Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation. Mol Cell Biochem 1992, 115:203-221.
37. Potter LR, Hunter T. Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor. J Biol Chem 1998, 273:15533-15539. 10.1074/jbc.273.25.15533, 9624142.
38. Liu Y, Ruoho AE, Rao VD, Hurley JH. Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis. Proc Natl Acad Sci U S A 1997, 94:13414-13419. 10.1073/pnas.94.25.13414, 28319, 9391039.
39. Sunahara RK, Beuve A, Tesmer JJ, Sprang SR, Garbers DL, Gilman AG. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J Biol Chem 1998, 273:16332-16338. 10.1074/jbc.273.26.16332, 9632695.
40. Tucker CL, Hurley JH, Miller TR, Hurley JB. Two amino acid substitutions convert a guanylyl cyclase, RetGC-1, into an adenylyl cyclase. Proc Natl Acad Sci U S A 1998, 95:5993-5997. 10.1073/pnas.95.11.5993, 27573, 9600905.
41. van den Akker F, Zhang X, Miyagi M, Huo X, Misono KS, Yee VC. Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature 2000, 406:101-104. 10.1038/35017602, 10894551.
42. Labrecque J, Mc Nicoll N, Marquis M, De Lean A. A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity. Role of receptor dimerization in signal transduction. J Biol Chem 1999, 274:9752-9759. 10.1074/jbc.274.14.9752, 10092664.
43. Wilson EM, Chinkers M. Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry 1995, 34:4696-4701. 10.1021/bi00014a025, 7718574.
44. Yang RB, Garbers DL. Two eye guanylyl cyclases are expressed in the same photoreceptor cells and form homomers in preference to heteromers. J Biol Chem 1997, 272:13738-13742. 10.1074/jbc.272.21.13738, 9153227.
45. Garbers DL, Lowe DG. Guanylyl cyclase receptors. J Biol Chem 1994, 269:30741-30744.
46. Qiu Y, Ogawa H, Miyagi M, Misono KS. Constitutive activation and uncoupling of the atrial natriuretic peptide receptor by mutations at the dimer interface. Role of the dimer structure in signalling. J Biol Chem 2004, 279:6115-6123.
47. He X, Chow D, Martick MM, Garcia KC. Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone. Science 2001, 293:1657-1662. 10.1126/science.1062246, 11533490.
48. van den Akker F. Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors. J Mol Biol 2001, 311:923-937. 10.1006/jmbi.2001.4922, 11556325.
49. De Lean A, McNicoll N, Labrecque J. Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interface. J Biol Chem 2003, 278:11159-11166. 10.1074/jbc.M212862200, 12547834.
50. Ohsaki Y, Yang HK, Le PT, Jensen RT, Johnson BE. Human small cell lung cancer cell lines express functional atrial natriuretic peptide receptors. Cancer Res 1993, 53:3165-3171.
51. Vesely DL. Atrial natriuretic peptides: anticancer agents. J Investig Med 2005, 53:360-365.
52. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Alli AA, Solivan SM, Gower WR, Vesely DL. Five cardiac hormones decrease the number of human small-cell lung cancer cells. Eur J Clin Invest 2005, 35:388-398. 10.1111/j.1365-2362.2005.01501.x, 15948900.
53. Vesely BA, Alli AA, Song SJ, Gower WR, Sanchez-Ramos J, Vesely DL. Four peptide hormones specific decrease (up to 97%) of human prostate carcinoma cells. Eur J Clin Invest 2005, 35:700-710. 10.1111/j.1365-2362.2005.01569.x, 16269020.
54. Vesely BA, McAfee Q, Gower WR, Vesely DL. Four peptides decrease the number of human pancreatic adenocarcinoma cells. Eur J Clin Invest 2003, 33:998-1005. 10.1046/j.1365-2362.2003.01262.x, 14636304.
55. Vesely BA, Song S, Sanchez-Ramos J, Fitz SR, Solivan SM, Gower WR, Vesely DL. Four peptide hormones decrease the number of human breast adenocarcinoma cells. Eur J Clin Invest 2005, 35:60-69. 10.1111/j.1365-2362.2005.01444.x, 15638821.
56. Gower WR, Vesely BA, Alli AA, Vesely DL. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP. Int J Gastrointest Cancer 2005, 36:77-87. 10.1385/IJGC:36:2:77, 16648657.
57. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR, Vesely DL. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers. Eur J Clin Invest 2006, 36:810-819. 10.1111/j.1365-2362.2006.01721.x, 17032349.
58. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR, Vesely DL. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide. Cancer Lett 2007, 254:94-101. 10.1016/j.canlet.2007.02.015, 17399891.
59. Eichelbaum EJ, Vesely BA, Alli AA, Sun Y, Gower WR, Vesely DL. Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours. Endocrine 2006, 30:325-332. 10.1007/s12020-006-0011-6, 17526945.
60. Vesely DL. Cardiac and renal hormones: anticancer effects in vitro and in vivo. J Investig Med 2009, 57:22-28.
61. Abdelalim EM, Tooyama I. NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death Dis 2011, 2:e127. 10.1038/cddis.2011.10, 3101807, 21390061.